Evaluations of Combination Chemotherapy(DAC-Tam) for Advanced Malignant Melanoma. Possible Patient Groups which may Show a Good Response Rate.

2001 ◽  
Vol 63 (5) ◽  
pp. 561-568
Author(s):  
Hideki KAMIYA ◽  
Hiroyuki KANOH ◽  
Naoki ICHIHASHI ◽  
Yoshiro ICHIKI ◽  
Hajime TAKAGI ◽  
...  
Keyword(s):  
Malignant Melanoma ◽  
Combination Chemotherapy ◽  
Response Rate ◽  
Good Response Rate ◽  
Advanced Malignant Melanoma ◽  
Patient Groups

Combination Chemotherapy with Vinblastine, Bcnu and Cisplatin in Advanced Malignant Melanoma

1991 ◽  
Vol 77 (3) ◽  
pp. 216-218 ◽  
Author(s):  
Giuseppe Cornelia ◽  
Antonio Daponte ◽  
Pasquale Cornelia ◽  
Rossana Casaretti ◽  
Vincenzo Iervolino ◽  
...  
Keyword(s):  
Malignant Melanoma ◽  
Combination Chemotherapy ◽  
Advanced Malignant Melanoma

Fotemustine, dacarbazine, vindesine combination chemotherapy in advanced malignant melanoma

1995 ◽  
Vol 5 (6) ◽  
pp. 419-424 ◽  
Author(s):  
O Rixe ◽  
C. Borel ◽  
D. Paraiso ◽  
A. Benhammouda ◽  
T. Petit ◽  
...  
Keyword(s):  
Malignant Melanoma ◽  
Combination Chemotherapy ◽  
Advanced Malignant Melanoma

Cisplatin and vindesine combination chemotherapy in advanced malignant melanoma: an EORTC phase II study

1982 ◽  
Vol 18 (12) ◽  
pp. 1297-1301 ◽  
Author(s):  
J.H. Mulder ◽  
P. Dodion ◽  
F. Cavalli ◽  
B. Czarnetzki ◽  
M. Clavel ◽  
...  
Keyword(s):  
Malignant Melanoma ◽  
Phase Ii ◽  
Combination Chemotherapy ◽  
Phase Ii Study ◽  
Advanced Malignant Melanoma

Combination Chemotherapy with Vinblastine, Bleomycin and Methotrexate in Dtic-resistant Metastatic Melanoma

1979 ◽  
Vol 65 (2) ◽  
pp. 237-240 ◽  
Author(s):  
Gianfranco Porcile ◽  
Mario Musso ◽  
Francesco Boccardo ◽  
Riccardo Rosso ◽  
Leonardo Santi
Keyword(s):  
Malignant Melanoma ◽  
Metastatic Melanoma ◽  
Combination Chemotherapy ◽  
Response Rate ◽  
Objective Response ◽  
Complete Response

Fifteen patients with metastatic DTIC-resistant malignant melanoma were treated with vinblastine, bleomycin and methotrexate combination chemotherapy. Three patients showed an objective response (one complete response). The therapy was well tolerated and easy to administer. This combination appears to produce in DTIC-resistant patients a response rate similar to that obtained with DTIC.

Sign in / Sign up

Export Citation Format

Share Document